KaplanMeier survival analysis revealed that the IGH group exhibited significantly poorer survival outcomes compared to the IGL group, suggesting that GSH may contribute to neoadjuvant chemotherapy resistance and lead to a worse prognosis in breast cancer patients
17,18,19,20,21 The only phenotypes that were causally associated with HU were gout and kidney disease
Preclinical studies show minimal toxicity in research models, though some reports note temporary fatigue, nausea, or mild injection-site irritation
This isn't about casual experimentation
Compare provider-reviewed options Research Snapshot Provider comparison Regulatory status, labels, trial records, and sponsor updates can change quickly for obesity-drug pipeline pages
Harvard Health Annual 3 Special Health Reports of your choosing Free shipping on all items If you enjoy your Harvard Health Online Total Vitality membership you can continue at the discounted rate of just $89.00/year billed automatically each year